<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="82468">
  <stage>Registered</stage>
  <submitdate>10/12/2007</submitdate>
  <approvaldate>12/12/2007</approvaldate>
  <actrnumber>ACTRN12607000632493</actrnumber>
  <trial_identification>
    <studytitle>Electronic Games to Aid Motivation to Exercise (eGAME)</studytitle>
    <scientifictitle>Active Video Games to Improve Body Composition and Physical Activity in Children</scientifictitle>
    <utrn />
    <trialacronym>eGAME</trialacronym>
    <secondaryid>HRC 07-077B</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Overweight/obese</healthcondition>
    <conditioncode>
      <conditioncode1>Public Health</conditioncode1>
      <conditioncode2>Health promotion/education</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Active video games (Sony EyeToy).  Children will receive an upgrade to their existing gaming hardware.  Observation over 6 months will establish use of the upgrade as well as associated changes to physical activity levels and body composition.</interventions>
    <comparator>No active video games will be given.  Children will continue with their existing gaming hardware.  Standard treatment.</comparator>
    <control>Active</control>
    <interventioncode>Behaviour</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Change in BMI - Body Mass Index (kg/m2, z-score and centile) from baseline to 3 and 6 months.</outcome>
      <timepoint>Baseline, 3 months and 6 months.</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Percent body fat (%)</outcome>
      <timepoint>Baseline, 3 months and 6 months.</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Waist circumference (cm)</outcome>
      <timepoint>Baseline, 3 months and 6 months.</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Physical fitness measured in VO2Max (ml/kg/min)</outcome>
      <timepoint>Baseline, 3 months and 6 months.</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Physical Activity Questionnaire for Children score (self-report physical activity levels)</outcome>
      <timepoint>Baseline, 3 months and 6 months.</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Average daily time spent in light to vigorous activities (minutes) as measured via accelerometry</outcome>
      <timepoint>Baseline, 3 months and 6 months.</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Average daily time spent in active video games (minutes) (self-report)</outcome>
      <timepoint>Baseline, 3 months and 6 months.</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Average daily time spent in non-active video games (minutes) (self-report)</outcome>
      <timepoint>Baseline, 3 months and 6 months.</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Potential participants will be eligible to participate if they are =10 and &lt;15 years, live in the greater Auckland area, own PlayStation2 or 3, play video games for 2 or more hours per week and are overweight according to Cole international cut-off values.</inclusivecriteria>
    <inclusiveminage>10</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>14</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>Yes</healthyvolunteer>
    <exclusivecriteria>Potential participants will be excluded if they already own active video games or have a medical condition that would prohibit exercise.</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Prevention</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment>Interested participants who meet all criteria and for whom consent/assent has been granted will undergo baseline assessment.
Following baseline data collection, consented participants will be randomly assigned to either active video gaming intervention or the control group by the Clinical Trials Research Unit (CTRU) central randomisation service. The researcher will access the CTRU central randomisation service to determine the randomisation allocation. The allocation sequence for randomisation is concealed up to the point of randomisation.</concealment>
    <sequence>Randomisation will be stratified by sex (female and male) and preferred self-identified ethnicity (Maori, Pacific, and non-Maori non-Pacific) using stratified blocked randomisation with variable block sizes (multiple of 2).</sequence>
    <masking>Open (masking not used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures />
    <endpoint>Efficacy</endpoint>
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Not Applicable</phase>
    <anticipatedstartdate>1/02/2008</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>330</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Completed</recruitmentstatus>
    <recruitmentcountry />
    <recruitmentstate />
    <countryoutsideaustralia>
      <country>New Zealand</country>
      <state>Auckland</state>
    </countryoutsideaustralia>
  </recruitment>
  <sponsorship>
    <primarysponsortype>University</primarysponsortype>
    <primarysponsorname>Ralph Maddison</primarysponsorname>
    <primarysponsoraddress>Clinical Trials Research Unit (CTRU)
University of Auckland
Private Bag 92019
Auckland</primarysponsoraddress>
    <primarysponsorcountry>New Zealand</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Government body</fundingtype>
      <fundingname>Health Research Council</fundingname>
      <fundingaddress>PO Box 5541
Wellesley Street
Auckland</fundingaddress>
      <fundingcountry>New Zealand</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>University</sponsortype>
      <sponsorname>Cliona Ni Mhurchu</sponsorname>
      <sponsoraddress>Clinical Trials Research Unit (CTRU)
University of Auckland
Private Bag 92019
Auckland</sponsoraddress>
      <sponsorcountry>New Zealand</sponsorcountry>
    </secondarysponsor>
    <othercollaborator>
      <othercollaboratortype>University</othercollaboratortype>
      <othercollaboratorname>Andrew Jull</othercollaboratorname>
      <othercollaboratoraddress>Clinical Trials Research Unit (CTRU)
University of Auckland
Private Bag 92019
Auckland</othercollaboratoraddress>
      <othercollaboratorcountry>New Zealand</othercollaboratorcountry>
    </othercollaborator>
    <othercollaborator>
      <othercollaboratortype>University</othercollaboratortype>
      <othercollaboratorname>Harry Prapavessis</othercollaboratorname>
      <othercollaboratoraddress>School of Kinesiology
University of Western Ontario
Thames Hall/3M centre
London
Ontario N6A 3K7</othercollaboratoraddress>
      <othercollaboratorcountry>Canada</othercollaboratorcountry>
    </othercollaborator>
    <othercollaborator>
      <othercollaboratortype>University</othercollaboratortype>
      <othercollaboratorname>Yannan Jiang</othercollaboratorname>
      <othercollaboratoraddress>Clinical Trials Research Unit (CTRU)
University of Auckland
Private Bag 92019
Auckland</othercollaboratoraddress>
      <othercollaboratorcountry>New Zealand</othercollaboratorcountry>
    </othercollaborator>
    <othercollaborator>
      <othercollaboratortype>University</othercollaboratortype>
      <othercollaboratorname>Anthony Rodgers</othercollaboratorname>
      <othercollaboratoraddress>Clinical Trials Research Unit (CTRU)
University of Auckland
Private Bag 92019
Auckland</othercollaboratoraddress>
      <othercollaboratorcountry>New Zealand</othercollaboratorcountry>
    </othercollaborator>
    <othercollaborator>
      <othercollaboratortype>University</othercollaboratortype>
      <othercollaboratorname>Stephen Vander Hoorn</othercollaboratorname>
      <othercollaboratoraddress>Clinical Trials Research Unit (CTRU)
University of Auckland
Private Bag 92019
Auckland</othercollaboratoraddress>
      <othercollaboratorcountry>New Zealand</othercollaboratorcountry>
    </othercollaborator>
    <othercollaborator>
      <othercollaboratortype>University</othercollaboratortype>
      <othercollaboratorname>David Schaff</othercollaboratorname>
      <othercollaboratoraddress>Pacific Health
University of Auckland
Private Bag 92019
Auckland</othercollaboratoraddress>
      <othercollaboratorcountry>New Zealand</othercollaboratorcountry>
    </othercollaborator>
  </sponsorship>
  <ethicsAndSummary>
    <summary>The main objective of this study is to determine the effects of active video games over 6 months on: body mass index (BMI), percent body fat, waist circumference, cardio-respiratory fitness, and physical activity levels in children.</summary>
    <trialwebsite />
    <publication>Feasibility, design and conduct of a pragmatic randomized controlled trial to reduce overweight and obesity in children:  The electronic games to aid motivation to exercise (eGAME) study 
Ralph Maddison, Louise Foley, Cliona Ni Mhurchu, Andrew Jull, Yannan Jiang, Harry Prapavessis, Anthony Rodgers, Stephen Vander Hoorn, Maea Hohepa and David Schaaf BMC Public Health 2009, 9:146 (19 May 2009)

http://www.biomedcentral.com/1471-2458/9/146</publication>
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Northern Y Ethics Committee</ethicname>
      <ethicaddress>3rd floor, BNZ building
354 Victoria St
PO Box 1031
Hamilton</ethicaddress>
      <ethicapprovaldate>31/10/2007</ethicapprovaldate>
      <hrec>NTY/07/09/099</hrec>
      <ethicsubmitdate />
      <ethiccountry>New Zealand</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Ralph Maddison</name>
      <address>Clinical Trials Research Unit (CTRU)
University of Auckland
Private Bag 92019
Auckland</address>
      <phone>64 9 3737599 x 84767</phone>
      <fax />
      <email>r.maddison@ctru.auckland.ac.nz</email>
      <country>New Zealand</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name>Louise Foley</name>
      <address>Clinical Trials Research Unit (CTRU)
University of Auckland
Private Bag 92019
Auckland</address>
      <phone>64 9 3737599 x 84612</phone>
      <fax />
      <email>l.foley@ctru.auckland.ac.nz</email>
      <country>New Zealand</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name>Louise Foley</name>
      <address>Clinical Trials Research Unit (CTRU)
University of Auckland
Private Bag 92019
Auckland</address>
      <phone>64 9 3737599 x 84612</phone>
      <fax />
      <email>regtrials@ctru.auckland.ac.nz</email>
      <country>New Zealand</country>
      <type>Updating Information</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>